{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:54:56Z","timestamp":1777532096185,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Defense (CZ)","award":["Long-Term Developing Plan 1011"],"award-info":[{"award-number":["Long-Term Developing Plan 1011"]}]},{"name":"University Hospital in Hradec Kralove (CZ)","award":["Project for Conceptual Development of Research Organization 00179906"],"award-info":[{"award-number":["Project for Conceptual Development of Research Organization 00179906"]}]},{"name":"University of Hradec Kralove (CZ)","award":["Long-Term Development Plan of University Hradec Kralove"],"award-info":[{"award-number":["Long-Term Development Plan of University Hradec Kralove"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s12640-015-9582-4","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T01:56:41Z","timestamp":1449626201000},"page":"267-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Small Quaternary Inhibitors K298 and K524: Cholinesterases Inhibition, Absorption, Brain Distribution, and Toxicity"],"prefix":"10.1007","volume":"29","author":[{"given":"Jana Zdarova","family":"Karasova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milos","family":"Hroch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Musilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"issue":"2","key":"9582_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbr.2009.05.002","volume":"203","author":"C Amourette","year":"2009","unstructured":"Amourette C, Lamproglou I, Barbier L, Fauquette W, Zoppe A, Viret R et al (2009) Gulf war illness: effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain. Behav Brain Res 203(2):207\u2013214","journal-title":"Behav Brain Res"},{"issue":"1","key":"9582_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1039\/B712109A","volume":"10","author":"J Arning","year":"2008","unstructured":"Arning J, Stolte S, Boschen A, Stock F, Pitner WR, Welz-Biermann U et al (2008) Qualitative and quantitative structure activity relationships for the inhibitory effects of cationic head groups, functionalised side chains and anions of ionic liquids on acetylcholinesterase. Green Chem 10(1):47\u201358","journal-title":"Green Chem"},{"issue":"7","key":"9582_CR3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s11172-012-0180-9","volume":"61","author":"EY Chernikova","year":"2012","unstructured":"Chernikova EY, Fedorov YV, Fedorova OA (2012) Cucurbituril as a new \u201chost\u201d of organic molecules in inclusion complexes. Russ Chem B 61(7):1363\u20131390","journal-title":"Russ Chem B"},{"issue":"8","key":"9582_CR4","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1021\/jm101299d","volume":"54","author":"A Conejo-Garcia","year":"2011","unstructured":"Conejo-Garcia A, Pisani L, Nunez MDC, Catto M, Nicolotti O, Leonetti F et al (2011) Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivity. J Med Chem 54(8):2627\u20132645","journal-title":"J Med Chem"},{"issue":"5","key":"9582_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-4431.2011.00672.x","volume":"21","author":"DS Foy","year":"2011","unstructured":"Foy DS, Trepanier LA, Shelton GD (2011) Cholinergic crisis after neostigmine administration in a dog with acquired focal myasthenia gravis. J Vet Emerg Crit Car 21(5):547\u2013551","journal-title":"J Vet Emerg Crit Car"},{"issue":"5","key":"9582_CR6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/WCO.0b013e3283572588","volume":"25","author":"NE Gilhus","year":"2012","unstructured":"Gilhus NE (2012) Myasthenia and the neuromuscular junction. Curr Opin Neurol 25(5):523\u2013529","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"9582_CR7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10928-013-9316-2","volume":"40","author":"N Holford","year":"2013","unstructured":"Holford N (2013) Disease progression and neuroscience. J Pharmacokinet Phar 40(3):369\u2013376","journal-title":"J Pharmacokinet Phar"},{"issue":"40","key":"9582_CR8","doi-asserted-by":"crossref","first-page":"38948","DOI":"10.1074\/jbc.M304797200","volume":"278","author":"JL Johnson","year":"2003","unstructured":"Johnson JL, Cusack B, Hughes TF, McCullough EH, Fauq A, Romanovskis P et al (2003) Inhibitors tethered near the acetylcholinesterase active site serve as molecular rulers of the peripheral and acylation sites. J Biol Chem 278(40):38948\u201338955","journal-title":"J Biol Chem"},{"issue":"1","key":"9582_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2478\/v10136-009-0005-9","volume":"8","author":"JZ Karasova","year":"2010","unstructured":"Karasova JZ, Stodulka P, Kuca K (2010) In vitro screening of blood-brain barrier penetration of clinically used acetylcholinesterase reactivators. J Appl Biomed 8(1):35\u201340","journal-title":"J Appl Biomed"},{"key":"9582_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2478\/v10136-011-0015-2","volume":"10","author":"JZ Karasova","year":"2012","unstructured":"Karasova JZ, Hnidkova D, Pohanka M, Musilek K, Chilcott RP, Kuca K (2012) Pharmacokinetics of acetylcholinesterase reactivator K203 and consequent evaluation of low molecular weight antioxidants\/markers of oxidative stress. J Appl Biomed 10:71\u201378","journal-title":"J Appl Biomed"},{"issue":"1","key":"9582_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-012-9329-4","volume":"23","author":"JZ Karasova","year":"2013","unstructured":"Karasova JZ, Zemek F, Musilek K, Kuca K (2013) Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous system. Neurotox Res 23(1):63\u201368","journal-title":"Neurotox Res"},{"issue":"1","key":"9582_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jab.2013.01.001","volume":"12","author":"JZ Karasova","year":"2014","unstructured":"Karasova JZ, Zemek F, Kassa J, Kuca K (2014) Entry of oxime K027 into the different parts of rat brain: comparison with obidoxime and oxime HI-6. J Appl Biomed 12(1):25\u201329","journal-title":"J Appl Biomed"},{"key":"9582_CR13","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.bmcl.2011.02.047","volume":"21","author":"M Komloova","year":"2011","unstructured":"Komloova M, Musilek K, Horova A, Holas O, Dohnal V, Gunn-Moore F et al (2011) Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors\u2014implications for early Myasthenia gravis treatment. Bioorg Med Chem Lett 21:2505\u20132509","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"9582_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/joa.12034","volume":"224","author":"I Koneczny","year":"2014","unstructured":"Koneczny I, Cossins J, Vincent A (2014) The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. J Anat 224(1):29\u201335","journal-title":"J Anat"},{"issue":"1","key":"9582_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","volume":"33","author":"R Leon","year":"2013","unstructured":"Leon R, Garcia AG, Marco-Contelles J (2013) Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer\u2019s disease. Med Res Rev 33(1):139\u2013189","journal-title":"Med Res Rev"},{"issue":"6","key":"9582_CR16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.22256","volume":"68","author":"RG Miller","year":"2010","unstructured":"Miller RG, Barohn RJ, Dubinsky R (2010) Expanding the evidence base for therapeutics in myasthenia gravis. An Neurol 68(6):776\u2013777","journal-title":"An Neurol"},{"issue":"3","key":"9582_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/138955711795049880","volume":"11","author":"PK Mukherjee","year":"2011","unstructured":"Mukherjee PK, Satheeshkumar N, Venkatesh P, Venkatesh M (2011) Lead finding for acetyl cholinesterase inhibitors from natural origin: structure activity relationship and scope. Mini-Rev Med Chem 11(3):247\u2013262","journal-title":"Mini-Rev Med Chem"},{"issue":"2","key":"9582_CR18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/14756366.2010.496362","volume":"26","author":"K Musilek","year":"2011","unstructured":"Musilek K, Pavlikova R, Marek J, Komloova M, Holas O, Hrabinova M et al (2011a) The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage. J Enzym Inhib Med Chem 26(2):245\u2013253","journal-title":"J Enzym Inhib Med Chem"},{"issue":"2","key":"9582_CR19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ejmech.2010.12.011","volume":"46","author":"K Musilek","year":"2011","unstructured":"Musilek K, Komloova M, Holas O, Hrabinova M, Pohanka M, Dohnal V et al (2011b) Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage\u2014implications for early Myasthenia gravis treatment. Eur J Med Chem 46(2):811\u2013818","journal-title":"Eur J Med Chem"},{"issue":"4","key":"9582_CR20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00280120","volume":"42","author":"K Ohtsubo","year":"1992","unstructured":"Ohtsubo K, Fujii N, Huguchi S, Aoyama T, Goto I, Tatsuhara T (1992) Influence of food on serum-ambenonium concentration in patients with myasthenia-gravis. Eur J Clin Pharmacol 42(4):371\u2013374","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"9582_CR21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ijch.201100065","volume":"51","author":"V Ramamurthy","year":"2011","unstructured":"Ramamurthy V, Parthasarathy A (2011) Chemistry in restricted spaces: select photodimerizations in cages, cavities, and capsules. Isr J Chem 51(7):817\u2013829","journal-title":"Isr J Chem"},{"issue":"4","key":"9582_CR22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0031-1279757","volume":"38","author":"F Schumm","year":"2011","unstructured":"Schumm F, Henze T (2011) Symptomatic treatment of myasthenia gravis and other neuromuscular transmission disorders. Aktuel Neurol 38(4):178\u2013189","journal-title":"Aktuel Neurol"},{"issue":"3","key":"9582_CR23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cei.12217","volume":"175","author":"JP Sieb","year":"2014","unstructured":"Sieb JP (2014) Myasthenia gravis: an update for the clinician. Clin Exp Immunol 175(3):408\u2013418","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"9582_CR24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF03189975","volume":"16","author":"C Tharassebloch","year":"1991","unstructured":"Tharassebloch C, Chabenat C, Boucly P, Marchand J, Elkharrat D, Bouclygoester C et al (1991) Pharmacokinetic studies of ambenonium chloride in patients with myasthenia-gravis. Eur J Drug Metab Ph 16(4):299\u2013303","journal-title":"Eur J Drug Metab Ph"},{"issue":"2","key":"9582_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11940-012-0213-6","volume":"15","author":"A Sonderen van","year":"2013","unstructured":"van Sonderen A, Wirtz PW, Verschuuren JJGM, Titulaer MJ (2013) Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, Lambert-Eaton myasthenic syndrome, and neuromyotonia. Curr Treat Opin Neurol 15(2):224\u2013239","journal-title":"Curr Treat Opin Neurol"},{"issue":"5\u20136","key":"9582_CR26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ijch.201100033","volume":"51","author":"S Walker","year":"2011","unstructured":"Walker S, Oun R, McInnes FJ, Wheate NJ (2011) The potential of cucurbit[n]urils in drug delivery. Isr J Chem 51(5\u20136):616\u2013624","journal-title":"Isr J Chem"},{"key":"9582_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-8981(99)00144-8","volume":"288","author":"F Worek","year":"1999","unstructured":"Worek F, Mast U, Kiderlen D, Diepold Ch, Eyer P (1999) Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288:73\u201390","journal-title":"Clin Chim Acta"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-015-9582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-015-9582-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-015-9582-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T18:01:55Z","timestamp":1748714515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-015-9582-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["9582"],"URL":"https:\/\/doi.org\/10.1007\/s12640-015-9582-4","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]}}}